about
Modeling the overall survival of patients with advanced-stage non-small cell lung cancer using data of routine laboratory tests.Biopsychosocial aspects of prostate cancer.The effects of test preference, test access, and navigation on colorectal cancer screeningGenetic polymorphism in a VEGF-independent angiogenesis gene ANGPT1 and overall survival of colorectal cancer patients after surgical resectionComprehensive analysis of common serum liver enzymes as prospective predictors of hepatocellular carcinoma in HBV patients.Gender differences in attitudes impeding colorectal cancer screening.Physician and patient factors associated with ordering a colon evaluation after a positive fecal occult blood testPost-diagnosis hemoglobin change associates with overall survival of multiple malignancies - results from a 14-year hospital-based cohort of lung, breast, colorectal, and liver cancers.Examining the role of perceived susceptibility on colorectal cancer screening intention and behavior.Genetic and environmental risk assessment and colorectal cancer screening in an average-risk population: a randomized trial.Aspartate aminotransferase to platelet ratio index as a prospective predictor of hepatocellular carcinoma risk in patients with chronic hepatitis B virus infectionObesity and Cancer Screening according to Race and Gender.A randomized controlled trial of a tailored interactive computer-delivered intervention to promote colorectal cancer screening: sometimes more is just the same.A survey of physician receptivity to molecular diagnostic testing and readiness to act on results for early-stage colon cancer patients.Predictors of patient uptake of colorectal cancer gene environment risk assessment.Increasing colon cancer screening in primary care among African Americans.Primary care colorectal cancer screening recommendation patterns: associated factors and screening outcomes.Genetic variations in stem cell-related genes and colorectal cancer prognosisAutomated telephone calls improved completion of fecal occult blood testingPostoperative hyperphosphatemia significantly associates with adverse survival in colorectal cancer patients.Cost-effectiveness of a standard intervention versus a navigated intervention on colorectal cancer screening use in primary careGWAS-identified colorectal cancer susceptibility locus associates with disease prognosis.Increasing access to clinical and educational studies.Physician recommendations for follow-up of positive fecal occult blood tests.Effects of genetic and environmental risk assessment feedback on colorectal cancer screening adherence.Circulating mitochondrial DNA content associated with the risk of liver cirrhosis: a nested case-control study.Depression in Korean immigrants with hepatitis B and related liver diseases.Cross-cultural validation of the preventive health model for colorectal cancer screening: an Australian study.Behaviors used by men to protect themselves against prostate cancer.Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result.Personal navigation increases colorectal cancer screening uptake.Perception, intention, and action in adolescent obesity.Worksite cancer screening and nutrition intervention for high-risk auto workers: design and baseline findings of the Next Step Trial.Genetic and environmental risk assessment for colorectal cancer risk in primary care practice settings: a pilot study.Erythropoiesis stimulating agents and clinical outcomes of invasive breast cancer patients receiving cytotoxic chemotherapy.Adherence to colorectal cancer screening in an HMO population.Factors associated with colorectal cancer screening decision stage.Factorial validity and invariance of a survey measuring psychosocial correlates of colorectal cancer screening in Ontario, Canada--a replication study.Modeling adherence to colorectal cancer screening.Telomere length in circulating serum DNA as a novel non-invasive biomarker for cirrhosis: a nested case-control analysis.
P50
Q30827122-EFD2D48C-F095-4DFD-A938-735A2032459BQ33882765-921B07BE-D7B1-46D0-AE74-EE53F45CD469Q33992396-A6768A75-EE4D-4FBC-82FE-76AD6FCB3E5CQ34230336-BDD8E7FA-9996-441F-B237-B73DCB374188Q34462246-22679B68-D2C4-47E5-AE06-4B8918B21EDFQ34739360-3D747518-2A99-4C12-88C9-AC2857273308Q34741635-C34DEEBC-4AAD-4F11-953C-6E9F23D81C8AQ34810071-52B1A17A-E06D-47C9-BE3B-0BF6547F51FDQ35179414-5872CEEB-1BE3-43D8-8D28-4C831BCF2F8CQ35545490-3DF36FA2-C013-4C77-80A6-FE6FAFF7051EQ35565542-BBCA28A9-73AB-4102-AD75-D973B8BE9AF5Q35636255-1675F90B-12EF-4765-A6BE-CF3FD937F834Q35694114-2C3CC114-F8CB-4962-8B89-9946F9B7E55EQ36156776-CE0408E4-E194-4D3B-A0D4-E68B037505A9Q36632881-969AB32F-3CC9-427A-AE09-77DD6C63B363Q36754895-2FB017D2-31A7-46AF-86E7-E6E42E8DFC0AQ36759309-5360D7CE-A58F-4FD6-8A04-4936A0ABD095Q37040950-CC861157-931B-4AEB-AC9B-57CA3B58FCFFQ37082441-9C84951C-5380-439F-BA89-B97DF1B44461Q37179265-21535A68-ADBE-44B1-BCC4-68503B11E92BQ37652888-265CF524-B2B7-49FD-BE5D-D39159BD81EFQ39608050-0B280B7F-1D94-4876-9752-7F6A57A96C8EQ40286660-36D4ACE4-E1A2-4C54-9670-42FB48C22619Q40455393-209BF5BF-DE86-422A-AE0E-63ABBEEADAA3Q41201094-AF5C4276-D756-473E-B6EA-F594D3D6B68FQ41545044-C579C172-B62F-4A35-9549-DD355C0838C5Q43835866-863A4EE0-E3E6-4E90-A570-ADB29DBF428BQ44096883-5A30D432-8579-47C9-89F1-92683848CF3EQ47241121-D875D259-ADCB-4C5D-B404-9FEA524E5666Q47617609-6B7D5358-2A71-4F08-986C-D38DFFA2C124Q47712349-6AADE7C5-3501-48CD-B2CF-B2D86C404339Q48316859-640AE50B-ECEA-42FD-8084-B43BCB844804Q50112039-C39BE26C-9B0F-4B21-8F6F-3DC588CBF5E5Q50691199-CE79F354-0479-4A91-9602-8C722FA9DC95Q51049616-11A97D37-EE69-4938-8137-034EF1AF595BQ51166036-DA542B83-B99C-4E4F-903B-55B25CE233F1Q51555274-2B14997B-9795-4B69-9D19-828FFCE92153Q51675062-05530ED8-BABB-4B94-AEAA-A4E549C1B89AQ52920575-E497BDE2-DB43-428F-BF92-4E5FEFCC6231Q53176007-FF726A4B-18FD-4552-9C30-15651DD1A971
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ronald E Myers
@nl
Ronald E Myers
@sl
Ronald E. Myers
@en
Ronald E. Myers
@es
type
label
Ronald E Myers
@nl
Ronald E Myers
@sl
Ronald E. Myers
@en
Ronald E. Myers
@es
prefLabel
Ronald E Myers
@nl
Ronald E Myers
@sl
Ronald E. Myers
@en
Ronald E. Myers
@es
P106
P1153
55737052100
P31
P496
0000-0002-8059-7390